| First Author | Braeuning A | Year | 2011 |
| Journal | Toxicol Sci | Volume | 123 |
| Issue | 1 | Pages | 113-22 |
| PubMed ID | 21705713 | Mgi Jnum | J:175082 |
| Mgi Id | MGI:5142348 | Doi | 10.1093/toxsci/kfr166 |
| Citation | Braeuning A, et al. (2011) Gender-Specific Interplay of Signaling through {beta}-Catenin and CAR in the Regulation of Xenobiotic-Induced Hepatocyte Proliferation. Toxicol Sci 123(1):113-22 |
| abstractText | Aberrant signaling through the Wnt/beta-catenin pathway is a critical determinant in human and rodent liver carcinogenesis and generally accepted to be a potent driver of proliferation. Xenobiotic agonists of the constitutive androstane receptor (CAR) induce massive acute hyperplasia of mouse liver and facilitate the outgrowth of hepatocellular carcinomas with activated beta-catenin. In the present study, the interplay of beta-catenin-dependent and CAR-dependent signaling in the liver and its effect on hepatocyte proliferation were analyzed in transgenic mice with hepatocyte-specific knockout of Ctnnb1 (encoding beta-catenin) following treatment with two CAR agonists, 1,4-bis[2-(3,5-dichloropyridyloxy)]-benzene (TCPOBOP) and phenobarbital. Hepatocyte-specific knockout of beta-catenin inhibited CAR agonists-induced hepatocyte proliferation in male mice. By contrast, the proliferative effect of CAR agonists was strongly augmented in female beta-catenin knockout animals. This was due to prolonged proliferation of the knockout hepatocytes. CAR-mediated hepatocyte proliferation was, at least in part, dependent on estrogen signaling and was associated with enhanced expression of FoxM1 and elevated activity of the PDK1/p90RSK pathway. In conclusion, our study shows that gender-specific factors determine whether beta-catenin signaling plays a pro- or an antiproliferative role in the regulation of mouse hepatocyte proliferation induced by CAR agonists. |
